What the research shows about statins and new-onset diabetes
Statins can increase the risk of developing type 2 diabetes, but the absolute risk remains small for most people. Large clinical trials have documented this effect consistently: people taking statins are roughly 9 to 13 percent more likely to develop diabetes than similar people not taking them. This does not mean statins cause diabetes in everyone who takes them—most statin users never develop diabetes—but the increased risk is real and measurable.
The mechanism is not fully understood. Statins work by blocking an enzyme in the liver that produces cholesterol, but they appear to also affect how the pancreas releases insulin and how cells respond to insulin. The effect seems to depend on the specific statin, the dose, and individual factors like age, weight, and family history of diabetes.
For most people, the cardiovascular benefit of taking a statin—preventing heart attack and stroke—outweighs the small increased diabetes risk. But this calculation changes depending on your personal risk profile, which is why the decision to start a statin should involve your doctor's assessment of your specific situation, not a general rule.
Key Takeaways
- Statins increase the risk of developing type 2 diabetes by roughly 9 to 13 percent, but most people taking statins do not develop diabetes.
- The risk appears higher with certain statins (particularly atorvastatin and rosuvastatin) and at higher doses than with others.
- People already at high risk for diabetes—those who are overweight, have a family history, or are over 60—face a larger absolute increase in risk.
- Your doctor can weigh your personal heart disease risk against your diabetes risk when deciding whether a statin is right for you.
- If you take a statin, monitoring blood sugar through routine checkups helps catch any changes early.
Which statins carry the highest diabetes risk
Not all statins increase diabetes risk equally. Atorvastatin (Lipitor) and rosuvastatin (Crestor)—two of the most commonly prescribed statins—show the strongest association with new-onset diabetes in research. Pravastatin (Pravachol) and pitavastatin (Livalo) show weaker associations, and some studies suggest pravastatin may carry minimal additional risk.
Higher doses also matter. Someone taking 80 mg of atorvastatin daily faces a larger diabetes risk than someone taking 10 mg. This dose relationship is one reason your doctor may start you on a lower dose and increase it only if needed, rather than jumping to the maximum dose immediately.
If you are already taking a statin and concerned about diabetes risk, do not stop taking it without talking to your doctor first. The cardiovascular protection may be more important than the diabetes risk in your particular case. Your doctor can discuss whether switching to a different statin or lowering your dose makes sense for you.
Who faces the highest risk while taking statins
Age is a major factor. People over 60 show a noticeably higher risk of statin-related diabetes than younger people. This is partly because older adults are more likely to already have prediabetes or metabolic changes that make them vulnerable to the additional statin effect.
Weight and metabolic health also matter. People who are overweight or have metabolic syndrome—a cluster of conditions including high blood pressure, high blood sugar, and excess belly fat—face a larger increase in diabetes risk from statins than lean, metabolically healthy people. Someone with a family history of diabetes is similarly at higher risk.
Women may face a slightly higher risk than men in some studies, though the difference is not dramatic. People taking higher doses of statins, particularly atorvastatin or rosuvastatin at 40 mg or higher, are at greater risk than those on lower doses.
How to monitor for diabetes if you take a statin
If your doctor prescribes a statin, ask about baseline blood sugar testing before you start. A fasting glucose test or hemoglobin A1c test establishes your starting point. This matters because it lets you and your doctor know whether you had undiagnosed prediabetes before the statin.
After starting a statin, routine checkups should include blood sugar monitoring. How often depends on your risk factors—someone at high risk for diabetes might have blood sugar checked annually, while someone at low risk might have it checked every few years as part of standard preventive care. Ask your doctor what schedule makes sense for you.
Watch for symptoms of high blood sugar: increased thirst, more frequent urination, fatigue, or blurred vision. These are not common side effects of statins, but they warrant a blood sugar test if they appear. Most statin-related diabetes develops gradually and without symptoms, which is why regular testing matters more than watching for signs.
When the cardiovascular benefit outweighs the diabetes risk
For people with established heart disease or a history of heart attack or stroke, statins reduce the risk of another event by roughly 20 to 30 percent. This substantial benefit usually outweighs the small increased diabetes risk. Your doctor will typically recommend a statin in these cases even if diabetes risk is a concern.
For people without heart disease but with multiple risk factors—high cholesterol, high blood pressure, smoking history, or strong family history of early heart disease—the calculation is more nuanced. Your doctor uses risk calculators (like the American College of Cardiology's ASCVD risk calculator) to estimate your 10-year heart disease risk. If that risk is above a certain threshold, the statin benefit usually wins.
For people at very low cardiovascular risk with no symptoms and no family history of early heart disease, the diabetes risk may tip the balance against starting a statin, particularly if you are already at high risk for diabetes. This is a conversation to have with your doctor based on your specific numbers, not a decision to make based on general advice.
Lifestyle changes that work alongside statin therapy
If you take a statin and are concerned about diabetes risk, the most effective step is weight loss if you are overweight. Even a 5 to 10 percent reduction in body weight improves insulin sensitivity and can offset some of the statin effect. Regular physical activity—150 minutes of moderate aerobic exercise per week—also improves how your body handles blood sugar.
Diet matters as well. A pattern emphasizing whole grains, vegetables, legumes, and fish over refined carbohydrates and processed foods helps prevent diabetes independent of statin use. You do not need a special "diabetes prevention diet"—the same eating pattern that supports heart health also supports healthy blood sugar.
Sleep and stress management are less direct but still relevant. Poor sleep and chronic stress both worsen insulin resistance. If you are taking a statin partly because of heart disease risk, addressing these factors helps your overall cardiovascular and metabolic health.
What happens if you develop diabetes while taking a statin
Developing diabetes while on a statin does not automatically mean you should stop the statin. Many people with both diabetes and high cholesterol benefit from continuing statin therapy because the heart disease prevention remains important. In fact, people with diabetes have higher cardiovascular risk than people without it, so statins are often recommended even more strongly.
Your doctor will likely start diabetes treatment—usually with lifestyle changes first, then medication if needed—while continuing the statin. The two conditions are managed separately but in coordination. Some diabetes medications, like GLP-1 agonists, may even help with weight loss, which can improve both cholesterol and blood sugar.
If you develop diabetes and feel the statin contributed, discuss it with your doctor. Switching to a different statin with lower diabetes risk, or lowering the dose, may be an option if your cardiovascular risk is not extremely high. But stopping the statin entirely is rarely the right answer once diabetes has developed.
Frequently Asked Questions
Does stopping a statin reverse diabetes caused by the statin?
Stopping a statin does not reliably reverse diabetes. Once diabetes develops, it usually persists even if the statin is discontinued. However, weight loss and increased physical activity after stopping the statin may help improve blood sugar control. The decision to stop a statin should involve your doctor, because the cardiovascular risk of stopping may outweigh the benefit of potentially improving blood sugar.
Are there cholesterol-lowering drugs that do not increase diabetes risk?
Other cholesterol medications like ezetimibe, PCSK9 inhibitors, and bempedoic acid do not appear to increase diabetes risk the way statins do. However, they are typically less powerful at lowering cholesterol and are often used alongside statins rather than instead of them. Your doctor can discuss whether alternatives or additions make sense for your situation.
Can I prevent statin-related diabetes with diet and exercise alone?
Diet and exercise reduce diabetes risk substantially, but they do not eliminate the increased risk that statins create. Someone taking a high-dose statin faces a higher diabetes risk than someone not taking a statin, even with excellent diet and exercise habits. That said, maintaining a healthy weight and staying active is still the most effective step you can take to lower your overall diabetes risk.
How long after starting a statin does diabetes usually develop?
There is no fixed timeline. Some people develop diabetes within the first year or two of starting a statin, while others never do despite years of use. This is why regular blood sugar monitoring matters—it catches changes whenever they occur, rather than waiting for symptoms to appear.
Should I ask my doctor to switch me to a different statin to reduce diabetes risk?
If you are concerned about diabetes risk, yes—this is a reasonable conversation to have. Pravastatin or pitavastatin carry lower diabetes risk than atorvastatin or rosuvastatin. However, your doctor may recommend staying on your current statin if it is controlling your cholesterol well and your cardiovascular risk is high. The decision depends on your individual numbers and risk profile.